LeMaitre Vascular Inc (LMAT) Analysts See $0.17 EPS

July 18, 2017 - By Nellie Frank

 LeMaitre Vascular Inc (LMAT) Analysts See $0.17 EPS
Investors sentiment decreased to 1.12 in 2016 Q4. Its down 0.44, from 1.56 in 2016Q3. It dived, as 11 investors sold LeMaitre Vascular Inc shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported.
Moreover, Panagora Asset Management has 0.02% invested in LeMaitre Vascular Inc (NASDAQ:LMAT) for 170,675 shares. Vanguard Gru has 0% invested in LeMaitre Vascular Inc (NASDAQ:LMAT). Continental Advsr Ltd Com invested in 0.58% or 84,900 shares. Jfs Wealth Limited Company holds 0.01% or 1,000 shares. Amer Century Incorporated holds 150,884 shares. Tfs Cap Ltd Liability Corp accumulated 53,568 shares. Millennium Mngmt Lc reported 0.01% in LeMaitre Vascular Inc (NASDAQ:LMAT). Blackrock Institutional Tru Na owns 0% invested in LeMaitre Vascular Inc (NASDAQ:LMAT) for 569,323 shares. Credit Suisse Ag accumulated 0% or 25,709 shares. 27,400 are owned by Bessemer Grp. Goldman Sachs Grp Inc Inc holds 13,667 shares. 8,249 were reported by Nationwide Fund Advsrs. Citigroup Inc accumulated 0% or 13,592 shares. Bancorp Of America Corp De holds 0% or 193,115 shares in its portfolio. Citadel Advsr Lc owns 8,563 shares or 0% of their US portfolio.

Since February 27, 2017, it had 0 insider purchases, and 9 insider sales for $8.92 million activity. $477,822 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) was sold by Kamke Trent G on Wednesday, May 24. $132,380 worth of LeMaitre Vascular Inc (NASDAQ:LMAT) shares were sold by Roberts David B. On Thursday, June 1 the insider Wijas Michael T sold $73,717.

Wall Street await LeMaitre Vascular Inc (NASDAQ:LMAT) to release earnings on July, 26. Analysts forecast EPS of $0.17, up exactly $0.03 or 21.43 % from 2014’s $0.14 EPS. The expected LMAT’s profit could reach $3.21 million giving the stock 43.50 P/E in the case that $0.17 earnings per share is reported. After posting $0.16 EPS for the previous quarter, LeMaitre Vascular Inc’s analysts now forecast 6.25 % EPS growth. The stock increased 1.51% or $0.44 during the last trading session, reaching $29.58. About 155,790 shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since July 18, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.

LeMaitre Vascular Inc (NASDAQ:LMAT) Ratings Coverage

Among 11 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 7 have Buy rating, 0 Sell and 4 Hold. Therefore 64% are positive. LeMaitre Vascular had 26 analyst reports since July 29, 2015 according to SRatingsIntel. On Thursday, September 10 the stock rating was initiated by Barrington Research with “Mkt Perform”. The firm has “Hold” rating by Canaccord Genuity given on Monday, July 10. TH Capital maintained it with “Buy” rating and $18 target in Monday, December 7 report. The rating was maintained by Cowen & Co on Thursday, April 21 with “Outperform”. As per Wednesday, July 29, the company rating was maintained by TH Capital. Dougherty & Company maintained it with “Buy” rating and $19 target in Monday, December 7 report. The firm earned “Buy” rating on Monday, December 7 by Roth Capital. As per Wednesday, January 20, the company rating was initiated by Sidoti. The company was maintained on Wednesday, July 29 by Benchmark. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, December 4.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The company has market cap of $558.10 million. The Firm develops, makes and markets medical devices and implants used primarily in the field of vascular surgery. It has a 49.29 P/E ratio. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

More notable recent LeMaitre Vascular Inc (NASDAQ:LMAT) news were published by: Nasdaq.com which released: “BUZZ-US STOCKS ON THE MOVE- Freeport-McMoRan, Abercrombie, Hawaii Telecom …” on July 10, 2017, also Seekingalpha.com with their article: “LeMaitre Vascular’s (LMAT) CEO George LeMaitre on Q1 2017 Results – Earnings …” published on April 27, 2017, Zacks.com published: “Is LeMaitre Vascular (LMAT) Great Growth Stock? November 01, 2016” on September 20, 2016. More interesting news about LeMaitre Vascular Inc (NASDAQ:LMAT) were released by: Globenewswire.com and their article: “LeMaitre Vascular Acquires Restore Flow Allografts” published on November 10, 2016 as well as Globenewswire.com‘s news article titled: “LeMaitre Vascular Will Announce Third Quarter 2016 Earnings Results on October …” with publication date: October 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.